Browse studies, page 699
Page 699 of 1,298, newest first. Search them all at once, ranked by relevance, in Evidence Hub.
- Evaluation and Management of Sepsis in Pulmonary Hypertension Journal of intensive care medicine, 2025
- Diagnosis and Treatment of Benign Prostatic Hyperplasia in Dogs: New Approaches Veterinary medicine international, 2025
- Antenatal Sildenafil for Congenital Diaphragmatic Hernia: A Systematic Review and Bayesian Meta-Analysis of Preclinical Studies Biomedicines, 2025
- Phosphodiesterase inhibitors as emerging therapeutics for skeletal disorders: A comprehensive review of mechanisms and repurposing potential Bone reports, 2026
- An overview on pharmaceutical applications of phosphodiesterase enzyme 5 (PDE5) inhibitors Molecular diversity, 2025
- Pharmacological treatment of bladder stent symptoms Bladder (San Francisco, Calif.), 2024
- Fetal Heart Failure: Exploring Diagnosis and Treatment Strategies Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2025
- Management of Pulmonary Arterial Hypertension: Current Strategies and Future Prospects Life (Basel, Switzerland), 2025
- From nanotechnology to immunomodulation: emerging strategies targeting macrophages in high altitude pulmonary hypertension Journal of nanobiotechnology, 2026
- The IL-12 family cytokines in neurodegenerative diseases: dual roles in neurotoxicity and neuroprotection Inflammopharmacology, 2025
- Management and Treatment of Benign Prostatic Hyperplasia Symptoms: Current Insights Research and reports in urology, 2025
- Pulmonary hypertension in pregnancy: hemodynamic challenges, maternal risk, and multidisciplinary management Journal of cardiovascular imaging, 2026
- The Pathophysiology, Mechanism, Diagnosis, and Management of Pulmonary Arterial Hypertension: A Comprehensive Literature Review US cardiology, 2026
- From symptomatic relief to restorative medicine: a comprehensive review of diabetic erectile dysfunction Translational andrology and urology, 2026
- Congenital Heart Disease and Pulmonary Arterial Hypertension: Current Perspectives Reviews in cardiovascular medicine, 2026
- Exploring the interconnectedness of multiple sclerosis and erectile dysfunction: mechanisms and management strategies Frontiers in cell and developmental biology, 2025
- The interplay between neuroinflammation and endothelial dysfunction in cerebral small vessel disease Frontiers in immunology, 2026
- Guideline of guidelines: a scoping review on comparison of major clinical guidelines for erectile dysfunction Translational andrology and urology, 2026
- Worldwide Epidemiology of Pulmonary Hypertension Associated With Left Heart Disease Cardiology discovery, 2026
- Myeloid-Derived Suppressor Cells: Function, Migration, and Therapeutic Opportunities in Glioblastoma Cells, 2026
- 2025 Annual Review of Pulmonary Arterial Hypertension Clinical Research Pulmonary therapy, 2026
- Unconsummated marriage: etiology and treatment of erectile dysfunction in newlywed men-a narrative review with a focus on China Translational andrology and urology, 2026
- Contemporary Management Strategies for Peyronie's Disease: A Comprehensive Review Research and reports in urology, 2026
- Erectile Dysfunction Drugs as Potential Therapy for Cognitive Decline: Preclinical and Translational Evidence Cells, 2025
- PDE-5 inhibitors in complex matrices: Recent updates on pretreatment and detection methods Journal of chromatography. A, 2026
- Pitfalls of Therapies Targeting the Nitric Oxide Signaling Pathway in Heart Failure With Preserved Ejection Fraction Journal of cardiovascular pharmacology, 2026
- Expert viewpoint on endpoints in systemic sclerosis: current and future outlook RMD open, 2026
- Overcoming MDSC-Mediated Immunosuppression in Hepatocellular Carcinoma: From Mechanisms to Novel Immunotherapeutic Approaches Cancers, 2026
- Comparative effectiveness of pharmacological treatments for fetal growth restriction: a network meta-analysis Frontiers in pharmacology, 2026
- Erectile Dysfunction: A Comprehensive Review of Pathophysiology, Diagnosis and Contemporary Management Medicina (Kaunas, Lithuania), 2026
- Clinical Updates in Pulmonary Hypertension Reviews in cardiovascular medicine, 2026
- Direct-to-Consumer Erectile Dysfunction Medications: is the Convenience Worth the Cost? Current urology reports, 2025
- Phytochemical-based nanomedicine as a promising therapeutic strategy for erectile dysfunction Asian journal of andrology, 2026
- Myeloid-derived suppressor cells in multiple myeloma: mechanistic insights and therapeutic implications Frontiers in immunology, 2026
- Dopamine receptors: Potential therapeutic targets for ischemia-reperfusion injury: A review International journal of biological macromolecules, 2026
- Targeting Inflammation-Oxidative Stress Crosstalk: Advances and Challenges in Nanocarrier-Based Interventional Strategies for Pulmonary Arterial Hypertension International journal of nanomedicine, 2026
- Tadalafil - a therapeutic option in the management of BPH-LUTS. International journal of clinical practice, 2014
- Current use of phosphodiesterase inhibitors in urology Turkish journal of urology, 2015
- Structure -activity relationships of PDE5 inhibitors Current medicinal chemistry, 2008
- Repositioning of Drugs in Cardiometabolic Disorders: Importance and Current Scenario Current topics in medicinal chemistry, 2016
- Novel therapeutic approaches in pulmonary arterial hypertension: focus on tadalafil Drugs of today (Barcelona, Spain : 1998), 2011
- PDE5 inhibitors: breaking new grounds in the treatment of COVID-19 Drug metabolism and personalized therapy, 2023
- The Phosphodiasterase 5-Inhibitors (PDE-5i) for Erectile Dysfunction (ED): A Therapeutic Challenge For Psychiatrists Current drug targets, 2018
- Modulating NO-GC Pathway in Pulmonary Arterial Hypertension International journal of molecular sciences, 2023
- Therapeutic Potential of Phosphodiesterase Inhibitors against Neurodegeneration: The Perspective of the Medicinal Chemist ACS chemical neuroscience, 2020
- Opportunities and challenges of pharmacotherapy for pulmonary arterial hypertension in children Pediatric pulmonology, 2021
- Latest pharmacotherapy options for benign prostatic hyperplasia Expert opinion on pharmacotherapy, 2014
- Potency, selectivity, and consequences of nonselectivity of PDE inhibition International journal of impotence research, 2004
- From nature to drug discovery: the indole scaffold as a 'privileged structure'. Mini reviews in medicinal chemistry, 2009
- Tadalafil, a further innovation in the treatment of sexual dysfunction Drugs of today (Barcelona, Spain : 1998), 2003
- Phosphodiesterase type 5 inhibitors: the day after European urology, 2007
- Prostaglandins as a Topical Therapy for Erectile Dysfunction: A Comprehensive Review Sexual medicine reviews, 2022
- Phosphodiesterase Type 5 Inhibitors and Visual Side Effects: A Narrative Review Journal of ophthalmic & vision research, 2021
- Current diagnosis and management of erectile dysfunction The Medical journal of Australia, 2019
- PDE-5 inhibition and sexual response: pharmacological mechanisms and clinical outcomes Annual review of sex research, 2002
- Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use Pharmacological reviews, 2006
- Erectile Dysfunction: Key Role of Cavernous Smooth Muscle Cells Frontiers in pharmacology, 2022
- Evaluation of tadalafil for the treatment of erectile dysfunction Zhonghua nan ke xue = National journal of andrology, 2008
- Phosphodiesterase inhibitors in Raynaud's phenomenon The Annals of pharmacotherapy, 2006
- Novel Insights Regarding Nitric Oxide and Cardiovascular Diseases Angiology, 2021
- PDE5 inhibitors in non-urological conditions Current pharmaceutical design, 2009
- Pharmacology of phosphodiesterase 5 inhibitors The Canadian journal of urology, 2003
- Gateways to Clinical Trials Methods and findings in experimental and clinical pharmacology, 2002
- Phosphodiesterase inhibitors in clinical urology Expert review of clinical pharmacology, 2013
- Update on pulmonary arterial hypertension pharmacotherapy Postgraduate medicine, 2016
- Sexual Activity in Patients with Cardiac Diseases Acta clinica Croatica, 2018
- Management of erectile dysfunction American family physician, 2010
- Pathological function of Ca2+-sensing receptor in pulmonary arterial hypertension Journal of smooth muscle research = Nihon Heikatsukin Gakkai kikanshi, 2014
- Screening of synthetic PDE-5 inhibitors and their analogues as adulterants: analytical techniques and challenges Journal of pharmaceutical and biomedical analysis, 2014
- Medication and dosage considerations in the prophylaxis and treatment of high-altitude illness Chest, 2008
- Pharmacotherapeutic management of pulmonary arterial hypertension Cardiology in review, 2010
- Pharmacology of phosphodiesterase-5 inhibitors International journal of clinical practice, 2002
- Phosphodiesterase inhibition in cognitive decline Journal of Alzheimer's disease : JAD, 2014
- Pharmacological management of erectile dysfunction BJU international, 2003
- Otorhinolaryngological adverse effects of urological drugs International braz j urol : official journal of the Brazilian Society of Urology, 2021
- Tadalafil and vardenafil vs sildenafil: a review of patient-preference studies BJU international, 2009
- Pulmonary arterial hypertension in pregnancy Seminars in perinatology, 2014
- PDE-5 inhibitors: clinical points Current drug targets, 2015
- Erectile dysfunction Actas urologicas espanolas, 2002
- Pharmacotherapy for pulmonary arterial hypertension Journal of thoracic disease, 2019
- Chronic PDE-5 inhibition in patients with erectile dysfunction - a treatment approach using tadalafil once-daily Expert opinion on pharmacotherapy, 2012
- New and Emerging Therapeutic Drugs for the Treatment of Pulmonary Arterial Hypertension: A Systematic Review Cureus, 2024
- Sildenafil and cardioprotection Current pharmaceutical design, 2013
- Pulmonary arterial hypertension Orphanet journal of rare diseases, 2013
- Drug-induced hearing loss Prescrire international, 2014
- Erectile dysfunction Le Journal medical libanais. The Lebanese medical journal, 2004
- Beyond Erectile Dysfunction: cGMP-Specific Phosphodiesterase 5 Inhibitors for Other Clinical Disorders Annual review of pharmacology and toxicology, 2023
- Erectile Dysfunction in Adolescents and Young Adults Current urology reports, 2024
- Lower Urinary Tract Symptoms in Men: A Review JAMA, 2025
- Nitric oxide synthases: regulation and function European heart journal, 2012
- ACVIM consensus statement guidelines for the diagnosis, classification, treatment, and monitoring of pulmonary hypertension in dogs Journal of veterinary internal medicine, 2020
- Diagnosis and Treatment of Pulmonary Arterial Hypertension: A Review JAMA, 2022
- Drug-Drug Interactions in the Management of Patients With Pulmonary Arterial Hypertension Chest, 2022
- Effectiveness and efficiency of guideline dissemination and implementation strategies International Journal of Technology Assessment in Health Care, 2004
- Development of spray-dried amorphous solid dispersions of tadalafil using glycyrrhizin for enhanced dissolution and aphrodisiac activity in male rats Saudi Pharmaceutical Journal, 2020
- Diketopiperazine-Based, Flexible Tadalafil Analogues: Synthesis, Crystal Structures and Biological Activity Profile Molecules, 2021
- Tadalafil Alleviates LPS-Induced Inflammation and Oxidative Stress of RWPE-1 Cell by Regulating the Akt/Nrf2 Signaling Pathway Inflammation, 2021
- Phosphodiesterase (PDE) 5 inhibitors sildenafil, tadalafil and vardenafil impact cAMP-specific PDE8 isoforms-linked second messengers and steroid production in a mouse Leydig tumor cell line Molecular and Cellular Endocrinology, 2021
- Therapy for Pulmonary Arterial Hypertension in Adults: Update of the CHEST Guideline and Expert Panel Report Chest, 2019
- Tadalafil-Loaded Self-Nanoemulsifying Chewable Tablets for Improved Bioavailability: Design, In Vitro, and In Vivo Testing Pharmaceutics, 2022
